This is a profile image of Gerti Pellumbi

Gerti Pellumbi

Senior PartnerWashington DC

Gerti Pellumbi

Senior PartnerWashington DC

Advises medical device, specialty pharmaceuticals, and pharmaceutical services companies across strategic, operational, organizational, and commercial topics

Gerti is a leader in medtech with more than 12 years of experience across cardiovascular, orthopedic, specialty-surgery, imaging, and diagnostics areas.

He has advised clients on a range of topics that include strategy, commercial models, M&A, postmerger integration, digital transformation, organization, and operations.

Examples of his recent client work include the following:

  • developing corporate strategy for leading global healthcare companies
  • collaborating with leading global medical-device companies on new US commercial models
  • performing portfolio analysis and strategy development for large life sciences companies
  • assisting healthcare-portfolio companies of leading US private-equity firms with 100-day plans, turnarounds, cost cutting, pricing, sales, marketing, and strategy development for
  • performing more than 15 strategic due diligences of healthcare assets in the Asia, Europe, and the United States for leading European and US private-equity firms
  • helping leading global investors with thematic investing in healthcare

Published work

What to expect from medtech in 2024,” McKinsey & Company, February 2024

Digital diagnostics: A path forward for IVD,” McKinsey & Company, December 2023

Accelerating growth in medtech: The next surge in portfolio moves,” McKinsey & Company, May 2022

Reimagining medtech for a COVID-19 world,” McKinsey & Company, April 2020

Bioelectronics ‘jump-start’ the next wave of device therapeutics,” McKinsey & Company, October 2019

Divestiture in medtech: Are you the natural owner of your businesses?,” McKinsey & Company, March 2019

Delivering growth: M&A in medical technology,” McKinsey & Company, January 2018

The growth imperative for medical-device companies,” McKinsey & Company, September 2017

“Under the lens: Does scale matter in medical technology?” Medtech Strategist, July 2015, Volume 2, Number 13

Value creation in medical device M&A,” McKinsey & Company, September 2014

Past experience

Merrill Lynch
Associate, Retail Investment Banking group

Circuit City
Senior financial analyst


University of Virginia, Darden School of Business

University of Maine
BS, finance, management information systems